diana1 42 Restless legs syndrome and impact on work performance January-April, 2009January-April, 2009January-April, 2009January-April, 2009January-April, 2009 Vol.28 - No.1 Vol.28 - No.1 Vol.28 - No.1 Vol.28 - No.1 Vol.28 - No.1 UNIVERSA MEDICINA Diana Samara* *Department of Occupational Medicine, Faculty of Medicine, Trisakti University Correspondence dr. Diana Samara, MKK Department of Occupational Medicine, Faculty of Medicine, Trisakti University Jl. Kyai Tapa No.260 - Grogol Jakarta 11440 Phone: 021-5672731 ext.2101 Email: davidwp@cbn.net.id Univ Med 2009; 28:34-40 ABSTRACT Restless legs syndrome (RLS) is a neurological sensorimotor disorder characterized by unpleasant sensations in the legs and an uncontrollable urge to move them for relief. The RSL prevalence in the general population is 0.1% - 11.5%, and increases with age, with the highest effect of producing a primary sleep disorder (70%-80%). Women appear to be at increased risk, as do individuals with certain chronic conditions, including renal failure and anemia. The pathophysiology of RLS is incompletely understood, but it probably results from derangements in dopamine and iron metabolism, and has a genetic component. RSL could be idiopathic or secondary (usually related with iron deficiency, terminal renal failure, pregnancy, and spinal cord lesions). RLS patients usually have sleep disorders, so the disease can cause difficulties and problems in occupational and social life. Subjects with RLS symptoms appear to experience significantly more daytime problems, including being late for work, making errors at work, or missing work because of sleepiness. The diagnosis of RLS is made by following the criteria of the International Restless Legs Syndrome Study Group (IRLSSG). Pharmacologic RLS therapy, in which dopaminergic drugs constitute the first line, is effective and may have a dramatic effect on symptoms and quality of life. Identifying and treating RLS may improve sleep quality, daytime function and work performance. Keywords: Restless legs syndrome, sleep disorder, workers INTRODUCTION R e s t l e s s l e g s s y n d r o m e ( R L S ) i s a n e u r o l o g i c a l s e n s o r i m o t o r d i s o r d e r characterized by by unpleasant sensations in the legs and an uncontrollable urge to move them for relief. The patients complain of a burning sensation, of worms moving, of a sudden pulling movement of the leg, or of ants crawling within the legs. The sensations range from uncomfortable to irritating and painful.(1,2) The urge to move the legs has a circadian pattern most occur in the evening or at night when the p a t i e n t i s n o t a c t i v e , a t w h i c h t i m e R L S symptoms are manifested as sudden movements of the legs, such that this condition is frequently 43 Univ Med Vol.28 - No.1 accompanied by sleep disturbances.(2) RSL may have a negative impact on the quality of life because it causes unpleasant waking up, chronic sleep disorders, and stress. This condition has an effect on various aspects of life, such as occupational and social problems and difficulties in family life. Disturbed sleep and intolerance to activities where the individual has to remain without moving, may cause loss of work, inability to enjoy life and relational problems.(3) Epidemiology In the general population, the prevalence of RSL ranges from 0.1% to 11.5%, with the occurrence of a primary sleep disorder as the highest effect (70%-80%).(4) Studies conducted by The RLS Epidemiology, Symptoms and Treatment (REST) have shown that among the majority of patients seeking relief, only 6.2% was diagnosed as RSL. The symptoms are more frequently associated with conditions such as back pain, arthritis, or peripheral neuropathy.(5) The ratio of females to males with RLS is 2:1, but this ratio does not differ significantly from the female to male ratio of respondents in all surveys6. A survey in Japan found that 5% of respondents had symptoms of RSL, whilst clinically significant RSL amounted to 1.5%.(7) In the RLS Epidemiology, Symptoms, and Treatment (REST) survey of 16,202 individuals in the United States and 5 European countries, which is perhaps the largest study conducted to date, 7% of participants screened positively for RLS.(8) A telephone interview of a random sample of 1803 adults in predominantly rural Kentucky found an age-adjusted RLS prevalence of 10%.(9) Results were similar in the Wisconsin Sleep Cohort, a prospective community-based epidemiologic study, in which 10.6% of 2821 participants reported RLS symptoms occurring at least weekly.(10) Rangarajan et al reported their f i n d i n g s o f a d o o r t o d o o r s u r v e y o n a l l individuals in Bangalore, India. They found a prevalence of 2.1% based on the International Restless Legs Syndrome Study Group (IRLSSG) criteria, and 1.2% of RSL patients had sleep disturbances.(11) A high prevalence of RLS symptoms was observed in one Idaho primary care population. B a s e d o n t h e R e s t l e s s L e g s S y n d r o m e Questionnaire (RLSQ), this study found that 504 (24.0%) of the 2099 patients surveyed reported all 4 basic diagnostic symptoms of RLS.(12) Etiology The main cause of RSL is not known. RSL m a y b e i d i o p a t h i c o r s e c o n d a r y ( u s u a l l y associated with iron deficiency, terminal renal failure, pregnancy, and spinal cord lesions). A d d i t i o n a l s t u d i e s i n d i c a t e t h a t R S L i s associated with type 2 diabetes mellitus and m u l t i p l e s c l e r o s i s . H a l f o f p a t i e n t s w i t h idiopathic RLS have a positive family history of RLS.(2,4) Several studies also found that caffeine, alcohol, and tobacco may induce symptoms in individuals with a predisposition for developing RLS. A number of studies have shown that using a reduced amount of the substances, or not using them at all, may relieve the symptoms, although it is unclear whether elimination of these s u b s t a n c e s c o u l d a l t o g e t h e r p r e v e n t t h e occurrence of RLS symptoms.(1) Pathophysiology The basic pathophysiologic mechanism of RLS is incompletely understood. Pharmacologists, physiologists, pathologists, and neuroradiologists have found an association of RLS with dopamine transmission. Dopamine is a messenger molecule responsible for transmission of signals between one area of the brain, i.e. the substantia nigra, and the next relay station in the brain, which is the corpus striatum, resulting in smoothly coordinated activity of muscles as intended. It 44 is this dopamine transmission that is believed to play a role in the development of RLS.(1,13) Additionally, the development of RSL is also thought to be associated with a low iron store in the neurons of the substantia nigra and with spinal cord dysfunction.(2,13) Symptomatology Patients with RSL have uncomfortable sensations in the legs, particularly when sitting or lying down, accompanied with an urge to move the legs. These sensations are usually felt in the legs between the knee and the ankle, but occasionally also in the feet, thighs, arms and hands. The sensations mostly appear on both sides of the body (bilaterally), but may also be on one side only (unilateral). Most of the symptoms are ignored in daytime settings and a r e o n l y f e l t i n t h e e v e n i n g o r a t n i g h t , particularly when asleep. Most of the symptoms disappear by morning, when the patient is at last able to get some sleep. The symptoms may occur at any stage of life, but commonly become increasingly frequent with advancing age.(1) R e s t l e s s l e g s s y n d r o m e a n d w o r k performance Most patients with RLS suffer from a sleep disorder called periodic limb movements in sleep (PLMS). Individuals with both RLS and PLMS have difficulty in falling asleep and s t a y i n g a s l e e p , a n d u s u a l l y f a l l a s l e e p a t daytime because of difficulty in falling asleep in the early morning hours. The National Sleep Foundation 2005 poll on 1,506 adults found associations for persons at risk for RLS and sleep behaviors, who had shorter durations of sleep (less than six hours nightly) and had symptoms of insomnia. In comparison to persons not at risk for RSL, they also stayed up longer than intended (several nights per week), took more than 30 minutes to fall asleep, and had more daytime fatigue (p < 0.05).(14) The RLS epidemiology, symptoms, and treatment (REST) study in which 16.202 adults aged > 18 years participated, showed that more than 75% of the RLS sufferers reported at least one sleep-related symptom. Disrupted sleep, an inability to fall asleep, and insufficient hours of s l e e p a r e e x p e c t e d c o n s e q u e n c e s o f t h e sensorimotor abnormalities of RLS, which are worse at night and while at rest.(15) Consequently persons suffering from RLS have problems at w o r k , i n s o c i a l l i f e a n d i n r e c r e a t i o n a l activities.(16) They frequently come late to work and make errors at work, due to sleepiness.(14) The study by Ulfberg et al in 200 women between 18-64 years of age, using multivariate logistic regression, found that 11.4% of the women suffered from RLS. These women with RLS had more sleep disturbances than those without RLS. The sleep disorder had an impact on their daily life, where RSL sufferers were f i v e t i m e s m o r e l i k e l y t o c o m p l a i n o f headaches, and tended to have diminished performance at work. In consequence, these conditions caused 9 times more problems at work among women with RSL.(17) A n u m b e r o f s t u d i e s , i n c l u d i n g t h e National Sleep Foundation 2005 Poll, have consistently reported the presence of a strong association between mental and physical health problems on the one hand and RLS symptoms on the other.(14,18,19) Diagnostic criteria Because of a lack of objective biological diagnostic signs, the diagnosis is based on the clinical criteria of the International Restless Legs Syndrome Study Group (IRLSSG), consisting of four essential and four supportive criteria. The four essential criteria are (i) an urge to move the legs, (ii) worse at rest or when inactive, (iii) relief by activities such as walking, and (iv) worse in the evening or at night. Supportive Samara Restless legs syndrome 45 Univ Med Vol.28 - No.1 clinical conditions include (i) family history of RSL, (ii) response to dopaminergic therapy, and (iii) periodic movement of the extremities at sleep or when awake but relaxed, and (iv) chronic symptoms occurring with varying degrees of sleep disturbance and generally w i t h o u t n e u r o l o g i c a l a b n o r m a l i t i e s o n examination (Table 1). ( 2 0 ) The movements usually occur periodically, on average at 20- second intervals. The most common movement is dorsoflexion of the ankle and flexion of the knee or hip.(3) In a number of dubious cases, neurophysiological examinations, such as polysomnography and/or immobilization tests, may be needed for confirmation of RSL.(4) Management N o t a l l p a t i e n t s w i t h R L S n e e d pharmacological treatment. Confirmation of diagnosis and reassurance is sufficient for most patients with RLS, and only approximately 20% of all RLS patients may have symptoms severe enough to merit pharmacological treatment.(21) RSL can be cured, although determining the most suitable treatment and dosage may take time, and treatment may occasionally have to be individually modified. Treatment should begin by examining the patient’s lifestyle and looking for opportunities to initiate lifestyle changes, especially with regard to substances known to exacerbate symptoms (Table 2).(22) Table 1. Diagnostic Criteria for Restless Legs Syndrome(20) Abbreviation: RLS, restless legs syndrome Table 2. Factors influencing treatment of RLS(22) 46 T h e p r i n c i p a l d r u g s u s e d i n pharmacological management of RSL are L- DOPA, dopamine agonists, anticonvulsants and benzodiazepines. Significant recovery with therapy occurs after a sufficiently long period of time.(2) T h e s t u d y c o n d u c t e d b y M o n t a g n a indicated that dopaminergic drugs constituted the first line in pharmacology for treatment of RSL, at least for a short period of time (Table 3).(23) A l t h o u g h m o s t p a t i e n t s r e q u i r e pharmacologic treatments, non-pharmacologic treatments are available from which patients m a y a l s o b e n e f i t . ( 2 4 ) M o s t o f t h e n o n - pharmacologic treatments for RLS are from case series or case reports; however, one small randomized study assessed the effects of e x e r c i s e o n R L S i n 2 8 i n d i v i d u a l s . ( 2 5 ) Participants were assigned to no exercise (n=17) or thrice weekly lower body resistance training and treadmill walking (n=11). Severity as measured by the International Restless Legs Syndrome (IRLS) scale decreased by 39% during the first 6 weeks of the intervention. This improvement was maintained for the remaining 6 weeks of the study period. In addition to moderate exercise, good sleep hygiene, including rising and going to bed at the same times e a c h d a y, s h o u l d f o r m t h e b a s i s f o r n o n - pharmacologic treatment of RLS. (26,27) Little information is available about the effects of lifestyle on the symptoms of RLS. Limiting caffeine, tobacco, and alcohol use may improve s y m p t o m s . A c t i v i t i e s t h a t p r o v i d e m e n t a l stimulation may also provide relief. One survey showed a higher prevalence of RLS in persons who were sedentary and overweight.(28) Many experts recommend abstaining from alcohol, caffeine, and nicotine. Activities that improve mental alertness (crossword puzzles, video games) may also reduce R L S s y m p t o m s ( 2 9 ) H o t b a t h s , m a s s a g e , a n d stretching may also improve symptoms.(30) Prognosis RLS has a variable course, but symptoms tend to progress with advancing age. Some i n d i v i d u a l s m a y e x p e r i e n c e s p o n t a n e o u s improvement in their symptoms for a period of time, but symptoms tend to recur.(31) Individuals with RLS secondary to an underlying condition m a y h a v e i m p r o v e m e n t o f s y m p t o m s i f t h e underlying condition is treated. Medications, when needed, may provide relief of symptoms. Table 3 Recommendations for primary RSL therapy(23) Abbreviation: RLS, restless legs syndrome; PLMS : periodic limb movements in sleep Samara Restless legs syndrome 47 Univ Med Vol.28 - No.1 CONCLUSIONS RLS is a disorder that frequently causes sleep disturbances, which if sufficiently severe will result in impairment of daily activities of life and thus may cause work-related problems. Therefore an accurate diagnosis of RLS needs to be made to prevent increasing the numbers of patients with sleep disturbances, which will have an impact on their work. The physician should have an increased understanding and a w a r e n e s s o f t h e c o n d i t i o n , t o p r e v e n t m i s d i a g n o s i s a n d c o n s e q u e n t i n e ff e c t i v e treatment. Identifying and treating RLS may improve sleep quality and daytime function. REFERENCES 1. Restless Legs Syndrome. National Institute of Neurological Disorder and Stroke Available at: http://www.ninds.nih.gov/disorders/restless_legs/ restless_legs.htm. Accessed December 3, 2008. 2. Sonka K, Kemlink D. Restless legs syndrome in 2004. Prague Med Rep 2004; 105: 337-56. 3. National Heart Lung and Blood Institute Working Group on Restless Legs Syndrome. Restless legs syndrome: detection and management in primary care. Am Fam Physician 2000; 62: 108-14. 4. Merlino G, Valente M, Serafini A, Gigli GL. Restless legs syndrome: diagnosis, epidemiology, classification, and consequences. Neurol Sci 2007; 28: (Suppl 1): S37-46. 5. Agarwal P, Griffith A. Restless legs syndrome: a unique case and essentials of diagnosis and treatment. Medscape J Med 2008; 1012: 296. 6. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004; 5: 237–46. 7. Kageyama T, Kabuto M, Nitta H, Kurokawa Y, Taira K, Suzuki S, et al. Prevalences of periodic limb movement-like and restless legs-like symptoms among Japanese adults. Psychiatry Clin Neurosci 2000; 54: 296–8. 8. McCrink L, Allen RP, Wolowacz S, Sherrill B, Connolly M, Kirsch J. Predictors of health-related quality of life in sufferers with restless legs syndrome: a multi-national study. Sleep Med 2007; 8: 73-83. 9. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Int Med 2000; 160: 2137-41. 10. Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin sleep cohort. Sleep Med 2006; 7: 545-52. 11. Rangarajan S, Rangarajan S, D’Souza GA. Restless legs syndrome in an Indian urban population. Sleep Med 2007; 8: 247-51. 12. Nichols DA, Allen RP, Grauke JH, Brown JB, Rice ML, Hyde PR, et al. Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med 2003; 163: 2323-9. 13. Paulus W, Dowling P, Rijsman R, Stiasny-Kolster K, Trenkwalder C, De Weerd A, et al. Pathophysiological concepts of restless legs syndrome. Mov Disord 2007; 22: 1451-6. 14. Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006; 129: 76–80. 15. Allen RP, Walters AS, Montplaisir J, Hening H, Myers A, Bell TJ, Ferini-Strambi L. Restless legs syndrome prevalence and impact. Arch Intern Med 2005; 165: 1286-92. 16. The Foundation for Better Health Care. Restless legs syndrome. Available at: http://www.fbhc.org/ Patients/Modules/rls.cfm. Accessed December 17, 2008. 17. Nyström JUB, Carter N, Edling C. Restless legs syndrome among working-age women. Eur Neurol 2001; 46: 17-9. 18. Rothdach AJ, Trenkwalder C, Haberstock J. Prevalence and risk factors of RLS in an elderly population: the MEMO study; memory and morbidity in Augsburg elderly. Neurology 2000; 54: 1064–8. 19. Berger K, Luedemann J, Trenkwalder C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004; 164: 196–202. 20. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-19. 48 21. Chaudhuri KR. The restless legs syndrome: time to recognize a very common movement disorder. Prac Neurol 2003; 3: 204–13. 22. DeKokker A, Whitehead H, Chaudhuri KR. Therapeutic strategies in restless legs syndrome. Future Prescriber 2005; 6: 5–10. 23. Montagna P. The treatment of restless legs syndrome. Neurol Sci 2007; 28: S61-S6. 24. Ryan M, Slevin JT. Restless Legs Syndrome. J Phar Pract 2007; 20; 6: 430–48. 25. Aukerman M, Aukerman D. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med 2006; 19: 487-93. 26. Parker KP, Rye DB. Restless legs syndrome and periodic limb movement disorder. Nurs Clin N Am 2002; 37: 655-73. 27. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999; 22: 970-99. 28. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000; 160: 2137-41. 29. Silber MH, Ehrenberg BL, Allen RP. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004; 79: 916-2. 30. Parker KP, Rye DB. Restless legs syndrome and periodic limb movement disorder. Nurs Clin N Am. 2002; 37: 655-73. 31. Bayard M, Avonda T, Wadzinski J. Restless legs syndrome. Am Fam Physician 2008; 78: 235-40. Samara Restless legs syndrome